Therapeutic and pleiotropic effects of statins for primary and secondary prevention of cardiovascular diseases;Effets thérapeutiques et pléiotropiques des statines dans la prévention primaire et secondaire de l'athérosclérose

Bulletin de l'Academie Nationale de Medecine

Volumn 185, Issue 1, 2001, Pages 49-60

  Bruckert, Éric ^a  

^a U Prev Maladies Cardiovasculaires   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; MEVINOLIN;

ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; DRUG COMBINATION; HUMAN; RESEARCH; REVIEW;

ANTICHOLESTEREMIC AGENTS; ARTERIOSCLEROSIS; CORONARY DISEASE; DRUG THERAPY, COMBINATION; HUMANS; LOVASTATIN; RESEARCH;

EID: 0009891671     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)34589-3     Document Type: Article

References (28)

1. CROMWELL W.C., ZIAJKA P.E. - Development of tachyphylaxis among patients taking HMG CoA reductase inhibitors. Am J Cardiol, 2000, 86, 1123-1127.
2. HOKANSON J.E., AUSTIN M.A - Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level : a meta-analysis of population-based prospective studies. J Cardiovasc Risk, 1996, 3, 213-9.
3. JEPPESEN J., HEIN H.O., SUADICANI P., GYNTELBERG F. - Triglyceride concentration and ischemic heart disease. An eight-year follow-up in the Copenhagen male study. Circulation, 1998, 97, 1029-36.
4. AUSTIN M.A., MCKNIGHT B., EDWARDS K.L., BRADLEY C.M., MCNEELY M.J., PSATY B.M., BRUNZELL J.D., MOTULSKY A.G. - Cardiovascular disease mortality in familial forms of hypertriglyceridemia : A 20-year prospective study. Circulation, 2000, 101, 2777-82.
5. BRUCKERT E., DE GENNES J.L., MALBECO W., BAIGTS F. - Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia. Clin Cardiol, 1995, 18, 621-9.
6. STEIN E. A, LANE M., LASKARZEWSKI P.P. - Comparison of statins in hypertriglyceridemia. Am J Cardiol. 1998, 81 (4A), 66B-69B.
7. BURNETT J.R., WILCOX L.J., TELLORD D.E., KLEINSTIVER S.J., BARRETT P.H., NEWTON R.S, HUFF M.W. - The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs. Endocrinology, 1999, 140, 5293-302.
8. GRUNDY S.M. - Consensus Statement - The Role of Therapy With «Statins» in Patients with Hypertriglyceridemia. Am J Cardiol, 1998, 81 (4A), 1B-6B.
9. RUBINS H.B., ROBINS S.J., COLLINS D. et al. - Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of HDL-cholesterol. N Engl J Med, 1999, 341, 410-8.
10. Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery Disease : The Bezafibrate Infarction Prevention (BIP) Study. Circulation, 2000, 102, 21-7.
11. LAROSA J.C, HE J., VUPPUTURI S. - Effect of statins on risk of coronary disease : a metaanalysis of randomized controlled trials. JAMA, 1999, 282, 2340-6.
12. VAUGHAN C.J., GOTTO A.M JR., BASSON C.T. - The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol, 2000, 35, 1-10.
13. PROSSER L.A., STINNETT A.A, GOLDMAN P.A, WILLIAMS LW, HUNINK M.G., GOLDMAN L., WEINSTEIN M.C. - Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med, 2000, 132, 769-79.
14. GANZ D.A., KUNTZ K.M., JACOBSON G.A, AVORN J. - Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarction. Ann Intern Med, 2000, 132, 780-7.
15. KEOGH A., MACDONALD P., KAAN A., ABOYOUN C., SPRATT P., MUNDY J. - Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation. J Heart Lung Transplant. 2000, 19, 529-37.
16. ROSENSON R.S. - Non-lipid-lowering effects of statins on atherosclerosis. Curr Cardiol Rep, 1999, 1, 225-32.
17. CORSINI A., PAZZUCCONI F., ARNABOLDI L., PFISTER P., FUMAGALLI R., PAOLETTI R., SIRTORI C.R. - Direct effects of statins on the vascular wall. J Cardiovasc Pharmacol, 1998, 31, 773-778.
18. TREASURE C.B., KLEIN J.L., WEINTRAUB W.S., TALLEY J.D., et al. - Beneficial effects of cholesterol lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med, 1995, 332, 481-487.
19. EGASHIRA K., HIROOKA Y, KAI H., SUGIMACHI M., SUSUKI S., INOU T., et al. - Reduction in serum cholesterol with pravastatin improves endothelium-dependant coronary vasomotion in patients with hypercholesterolemia. Circulation, 1994, 89, 2519-2524.
20. O'DRISCOLL G., GREEN D, TAYLOR R.R. - Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within a month. Circulation, 1997, 95, 1126-1131.
21. JOHN S.M., SCHLAICH M., LANGELFELD H., WEIHPRECHT G., SCHMITZ G., WEIDINGER R.F., SCHMIEDER. G. - Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients. A randomized, placebo-controlled, double-blind study. Circulation, 1998, 98, 211-216.
22. KLEINVELD H.A, DEMACKER P.N, DE HAAN A.F, STALENHOEF A.F. - Decreased in vitro oxydability of LDL in hypercholesterolemic patients treated with HMG-CoA reductase inhibitors. Eur J Clin Invest. 1993, 23, 289-295.
23. BORGHI C., PRANDIN M.G., COSTA F.V., BACCHELLI S., DEGLI ESPOSTI D., AMBROSIONI E. - Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia. J Cardiovasc Pharmacol, 2000, 35, 549-55.
24. CHAN K.A, ANDRADE S.E. BOLES M., BUIST D.S, CHASE G.A, DONAHUE J.G, GOODMAN M.J., GURWITZ J.H., LACROIX A.Z., PLATT R. - Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet, 2000, 355, 2185-8.
25. DELL'OMO G., BANDINELLI S., PENNO G., PEDRINELLI R., MARIANI M. - Simvastatin, capillary permeability, and acetylcholine-mediated vasomotion in atherosclerotic, hypercholesterolemic men. Clin Pharmacol Ther, 2000, 68, 427-34.
26. BLAIR S.N., CAPUZZI D.M., GOTTLIEB S.O., NGUYEN T., MORGAN J.M., CATER N.B. - Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am J Cardiol, 2000, 86, 46-52.
27. BRUCKERT E., SIMONETTA C., GIRAL P - Compliance with fluvastatin treatment characterization of the noncompliant population within a population of 3 845 patients with hyperlipidemia. CREOLE Study Team. J Clin Epidemiol, 1999, 52, 589-94.
28. MAJEED A., MOSER K., MAXWELL R. - Age, sex and practice variations in the use of statins in general practice in England and Wales. J Public Health Med, 2000, 22, 275-9.